Archives
-
Nintedanib (BIBF 1120) Assay Guide
2026-09-12
A scenario-driven guide to using Nintedanib (BIBF 1120), SKU A8252, in viability, apoptosis, proliferation, and cytotoxicity workflows. It connects documented kinase potency, formulation, storage, and ATRX-relevant literature to practical experimental decisions.
-
Amyloid Beta-Peptide (1-40): Applied Workflows
2026-09-11
Build reproducible amyloid fibril formation studies, membrane-interaction assays, and cell-based neurotoxicity mechanism investigations with a defined human Aβ40 model. The workflow combines controlled peptide handling with surface-sensitive spectroscopy to distinguish bulk aggregation from membrane-associated events.
-
DiscoveryProbe™ Immunology/Inflammation Compound Library
2026-09-11
The DiscoveryProbe Immunology/Inflammation Compound Library enables decision-focused immunomodulator screening across innate and adaptive immune phenotypes. This guide explains how to translate multiplex PBMC responses into target validation, pathway-level hypotheses, and better follow-up experiments.
-
Primidone, RIPK1, and ALS Biomarkers
2026-09-10
A 2023 study connected pharmacological RIPK1 inhibition with measurable changes in peripheral biomarkers in amyotrophic lateral sclerosis (ALS). Using SOD1G93A mice and a 24-week patient study, the authors found that Primidone reduced serum RIPK1 and IL-8, supporting a translational biomarker strategy while leaving questions about target engagement, specificity, and clinical efficacy open.
-
Palomid 529 in ESCC Research Workflows
2026-09-10
Palomid 529 (P529) provides a practical way to interrogate dual mTORC1 and mTORC2 signaling in esophageal squamous cell carcinoma models. This guide connects pathway validation with cisplatin resistance, metastasis, tumor angiogenesis inhibition, and radiotherapy enhancement while emphasizing reproducible dosing and troubleshooting.
-
SAG for Hedgehog Pathway Assays and Models
2026-09-09
SAG provides a controllable Smoothened receptor agonist signal for reporter assays, mechanistic inhibitor studies, neurobiology, developmental models, and translational disease research. This guide combines product-specific handling data with an assay strategy that distinguishes Smoothened-level effects from downstream GLI activity.
-
Rotavirus Suppression of Nrf2 Redox Defense
2026-09-09
The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive induction followed by pronounced loss of Nrf2 and its antioxidant transcriptional program. Its key contribution is linking late Nrf2 depletion to proteasome-sensitive, K48-linked ubiquitination rather than simply attributing the change to sustained oxidative stress.
-
Carbapenemase Gene Transmission in CREC
2026-09-08
Chen et al. combine gene localization, antimicrobial susceptibility, conjugation, mobile-element analysis, and genotyping to examine carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study shows that plasmid-associated blaNDM-1 is common and highly transferable, while strain relatedness and clinical distribution indicate simultaneous horizontal and vertical dissemination.
-
Anisomycin: JNK Agonist for Apoptosis Research
2026-09-08
Anisomycin is a JNK agonist and stress-signaling research compound used to study JNK pathway activation in apoptosis, cancer biology, and cellular stress. Product documentation identifies SKU B6674 as a 265.31 g/mol solid that is soluble in DMSO and ethanol but insoluble in water.
-
Deferiprone Workflows for Iron-Stress Research
2026-09-07
Deferiprone enables controlled iron depletion studies spanning enterocyte metabolism, tumor biology, oxidative stress, and vascular injury. This workflow-focused guide translates recent IPEC-J2 findings into practical dosing, repletion, metabolomics, and troubleshooting strategies.
-
JC-1 Mitochondrial Membrane Potential Assay Guide
2026-09-07
Learn how to use the JC-1 Mitochondrial Membrane Potential Assay Kit for ratiometric apoptosis assay design, drug screening, and mitochondrial function analysis. The workflow emphasizes CCCP controls, treatment-matched timing, and practical interpretation of mitochondrial depolarization in cancer research.
-
X-press Tag Peptide for Protein Purification
2026-09-05
X-press Tag Peptide is an N-terminal leader peptide that combines polyhistidine capture, an Xpress epitope, and an enterokinase cleavage site. Its documented 99.23% purity, ProBond compatibility, and anti-Xpress antibody detection support recombinant protein purification workflows, while the cited RHEB study provides biological context rather than direct product validation.
-
IPR-803: Urokinase Receptor Inhibitor Workflows
2026-09-04
IPR-803 is a competitive urokinase receptor inhibitor for separating uPAR–uPA signaling from general cell motility. Its use spans breast cancer invasion assays, metastasis models, and delivery-enabled pancreatic tumor-stroma research.
-
Substance P Workflows for Reproducible NK-1 Studies
2026-09-04
Build reproducible Substance P experiments for pain transmission research, neuroinflammation, and immune response modulation with water-based preparation and clearly staged controls. A fluorescence-quality-control strategy adapted from a recent reference study adds a practical way to detect matrix interference without overstating what EEM can prove.
-
PD 173074: An Epigenetics-Aware FGFR Assay Strategy
2026-09-03
PD 173074 enables precise investigation of FGFR1 and VEGFR2 signaling, but response can depend on cellular epigenetic context. This guide translates HNSCC methylation findings into a practical, target-engagement-focused assay strategy.